FDA declines to approve new form of HIV-associated lipodystrophy drug
FDA continues to review the file past the Prescription Drug User Fee Act goal date of January 22, 2024 MONTREAL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (œTheratechnologies or the...
This news release constitutes a œdesignated news release for the purposes of the Company™s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,...
Enforcement Report - Week of November 14, 2018